Harley-Davidson Motorcycle Recall Issued Due to Risk of Fuel Leaks and Fires

|

Harley-Davidson has recalled more than 111,000 family touring motorcycles after discovering that the fuel tanks could leak or catch fire after a crash.

The motorcycle manufacturer alerted the National Highway Traffic Safety Administration (NHTSA) of the recall, saying that it had detected the leaks after its own crash testing. There have been no injuries or deaths reported in connection to the defective fuel tanks.

The Harley-Davidson motorcycle recall affects 111,569 motorcycles from 22 different models of 2009 and 2010 Harley-Davidson Touring, CVO and Trike motorcycles. The bikes were manufactured between June 6, 2008 and November 19, 2009.

Sports-Betting-Addiction-Lawsuits
Sports-Betting-Addiction-Lawsuits

According to the NHTSA notice about the Harley-Davidson recall, the fuel tanks can begin leaking at the weld of the front bracket after a severe frontal collision. The leak could result in fire and injury or death of the rider.

Harley-Davidson dealers will begin installing braces on the left and right sides of the gas tank free of charge for Harley-Davidson owners whose bikes are affected by the recall. The braces are designed to reduce the amount of distortion that could occur during frontal accidents. Owners can contact the company at 1-414-343-4056 to see if their bikes are affected and to schedule a repair.


0 Comments


Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

MORE TOP STORIES

A neurosurgeon and a personal injury lawyer weigh in on new evidence linking Depo-Provera to brain tumors, as lawsuits mount against Pfizer over failure to warn about meningioma risks.